Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Liver transplant listing for hepatitis C associated cirrhosis and hepatocellular carcinoma has fallen in the United Kingdom since the introduction of direct acting antiviral therapy.

Vaziri A, Gimson A, Agarwal K, Aldersley M, Bathgate A, MacDonald D, McPherson S, Mutimer D, Gelson W.

J Viral Hepat. 2018 Oct 19. doi: 10.1111/jvh.13022. [Epub ahead of print]

PMID:
30339294
2.

Increased diagnosis and treatment of hepatitis C in prison by universal offer of testing and use of telemedicine.

Morey S, Hamoodi A, Jones D, Young T, Thompson C, Dhuny J, Buchanan E, Miller C, Hewett M, Valappil M, Hunter E, McPherson S.

J Viral Hepat. 2018 Oct 13. doi: 10.1111/jvh.13017. [Epub ahead of print]

PMID:
30315691
3.

A Placebo-Controlled, Multicenter, Double-Blind, Phase 2 Randomized Trial of the Pan-Caspase Inhibitor Emricasan in Patients with Acutely Decompensated Cirrhosis.

Mehta G, Rousell S, Burgess G, Morris M, Wright G, McPherson S, Frenette C, Cave M, Hagerty DT, Spada A, Jalan R.

J Clin Exp Hepatol. 2018 Sep;8(3):224-234. doi: 10.1016/j.jceh.2017.11.006. Epub 2017 Nov 22.

4.

Management of decompensated cirrhosis.

Mansour D, McPherson S.

Clin Med (Lond). 2018 Apr 1;18(Suppl 2):s60-s65. doi: 10.7861/clinmedicine.18-2-s60.

PMID:
29700095
5.

Care standards for non-alcoholic fatty liver disease in the United Kingdom 2016: a cross-sectional survey.

Sheridan DA, Aithal G, Alazawi W, Allison M, Anstee Q, Cobbold J, Khan S, Fowell A, McPherson S, Newsome PN, Oben J, Tomlinson J, Tsochatzis E.

Frontline Gastroenterol. 2017 Oct;8(4):252-259. doi: 10.1136/flgastro-2017-100806. Epub 2017 Apr 28.

6.

Summary of the British Transplantation Society UK Guidelines for Hepatitis E and Solid Organ Transplantation.

McPherson S, Elsharkawy AM, Ankcorn M, Ijaz S, Powell J, Rowe I, Tedder R, Andrews PA.

Transplantation. 2018 Jan;102(1):15-20. doi: 10.1097/TP.0000000000001908.

PMID:
28795981
7.

Lifestyle Behavior Change in Patients With Nonalcoholic Fatty Liver Disease: A Qualitative Study of Clinical Practice.

Avery L, Exley C, McPherson S, Trenell MI, Anstee QM, Hallsworth K.

Clin Gastroenterol Hepatol. 2017 Dec;15(12):1968-1971. doi: 10.1016/j.cgh.2017.06.011. Epub 2017 Jun 15. No abstract available.

8.

Effects of Exercise on Liver Fat and Metabolism in Alcohol Drinkers.

Houghton D, Hallsworth K, Thoma C, Cassidy S, Hardy T, Heaps S, Hollingsworth KG, Taylor R, Day CP, Masson S, McPherson S, Anstee QM, Trenell MI.

Clin Gastroenterol Hepatol. 2017 Oct;15(10):1596-1603.e3. doi: 10.1016/j.cgh.2017.05.001. Epub 2017 May 10.

PMID:
28501537
9.

A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis.

McPherson S, Wilkinson N, Tiniakos D, Wilkinson J, Burt AD, McColl E, Stocken DD, Steen N, Barnes J, Goudie N, Stewart S, Bury Y, Mann D, Anstee QM, Day CP.

PLoS One. 2017 Apr 18;12(4):e0175717. doi: 10.1371/journal.pone.0175717. eCollection 2017.

10.

Hepatitis C in a prison in the North East of England: what is the economic impact of the universal offer of testing and emergent medications?

Darke J, Cresswell T, McPherson S, Hamoodi A.

J Public Health (Oxf). 2016 Dec 2;38(4):e554-e562. doi: 10.1093/pubmed/fdv178. No abstract available.

PMID:
28158850
11.

Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled Trial.

Houghton D, Thoma C, Hallsworth K, Cassidy S, Hardy T, Burt AD, Tiniakos D, Hollingsworth KG, Taylor R, Day CP, McPherson S, Anstee QM, Trenell MI.

Clin Gastroenterol Hepatol. 2017 Jan;15(1):96-102.e3. doi: 10.1016/j.cgh.2016.07.031. Epub 2016 Aug 10.

12.

Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis.

McPherson S, Hardy T, Dufour JF, Petta S, Romero-Gomez M, Allison M, Oliveira CP, Francque S, Van Gaal L, Schattenberg JM, Tiniakos D, Burt A, Bugianesi E, Ratziu V, Day CP, Anstee QM.

Am J Gastroenterol. 2017 May;112(5):740-751. doi: 10.1038/ajg.2016.453. Epub 2016 Oct 11.

13.

Changing epidemiology of chronic liver disease among ethnic groups in the United States.

McPherson S, Anstee QM.

Hepatology. 2016 Dec;64(6):1843-1846. doi: 10.1002/hep.28783. Epub 2016 Oct 5. No abstract available.

PMID:
27533477
14.

Improving testing for hepatitis B before treatment with rituximab.

Dyson JK, Jopson L, Ng S, Lowery M, Harwood J, Waugh S, Valappil M, McPherson S.

Eur J Gastroenterol Hepatol. 2016 Oct;28(10):1172-8. doi: 10.1097/MEG.0000000000000689.

15.

Imagestream detection and characterisation of circulating tumour cells - A liquid biopsy for hepatocellular carcinoma?

Ogle LF, Orr JG, Willoughby CE, Hutton C, McPherson S, Plummer R, Boddy AV, Curtin NJ, Jamieson D, Reeves HL.

J Hepatol. 2016 Aug;65(2):305-13. doi: 10.1016/j.jhep.2016.04.014. Epub 2016 Apr 27.

PMID:
27132171
16.

Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease.

Hardy T, Zeybel M, Day CP, Dipper C, Masson S, McPherson S, Henderson E, Tiniakos D, White S, French J, Mann DA, Anstee QM, Mann J.

Gut. 2017 Jul;66(7):1321-1328. doi: 10.1136/gutjnl-2016-311526. Epub 2016 Mar 21.

17.

Response to the NCEPOD report: development of a care bundle for patients admitted with decompensated cirrhosis-the first 24 h.

McPherson S, Dyson J, Austin A, Hudson M.

Frontline Gastroenterol. 2016 Jan;7(1):16-23. Epub 2014 Dec 2. Review.

18.

Decompensated alcohol related liver disease: acute management.

McPherson S, Lucey MR, Moriarty KJ.

BMJ. 2016 Jan 26;352:i124. doi: 10.1136/bmj.i124. Review. No abstract available.

PMID:
26812946
19.

Reply to "Liver failure in human immunodeficiency virus - Hepatitis C virus coinfection treated with sofosbuvir, ledipasvir and antiretroviral therapy".

Dyson JK, McPherson S.

J Hepatol. 2016 Mar;64(3):753-4. doi: 10.1016/j.jhep.2015.11.038. Epub 2015 Dec 10. No abstract available.

PMID:
26682725
20.

Liver toxicity associated with sofosbuvir, an NS5A inhibitor and ribavirin use.

Dyson JK, Hutchinson J, Harrison L, Rotimi O, Tiniakos D, Foster GR, Aldersley MA, McPherson S.

J Hepatol. 2016 Jan;64(1):234-8. doi: 10.1016/j.jhep.2015.07.041. Epub 2015 Aug 29.

21.

Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management.

McPherson S, Hardy T, Henderson E, Burt AD, Day CP, Anstee QM.

J Hepatol. 2015 May;62(5):1148-55. doi: 10.1016/j.jhep.2014.11.034. Epub 2014 Dec 1.

22.

Lesson of the month 2: Severe reactivation of hepatitis B after immunosuppressive chemotherapy.

Dyson JK, Hudson M, McPherson S.

Clin Med (Lond). 2014 Oct;14(5):551-5. doi: 10.7861/clinmedicine.14-5-551.

PMID:
25301924
23.

Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging.

Dyson JK, Anstee QM, McPherson S.

Frontline Gastroenterol. 2014 Jul;5(3):211-218. Epub 2013 Dec 24. Review.

24.

TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease.

Liu YL, Reeves HL, Burt AD, Tiniakos D, McPherson S, Leathart JB, Allison ME, Alexander GJ, Piguet AC, Anty R, Donaldson P, Aithal GP, Francque S, Van Gaal L, Clement K, Ratziu V, Dufour JF, Day CP, Daly AK, Anstee QM.

Nat Commun. 2014 Jun 30;5:4309. doi: 10.1038/ncomms5309.

25.

Hepatitis B in pregnancy.

Dyson JK, Waller J, Turley A, Michael E, Moses S, Valappil M, Hudson M, Bassendine M, McPherson S.

Frontline Gastroenterol. 2014 Apr;5(2):111-117. Epub 2013 Oct 17.

26.

Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease.

McPherson S, Henderson E, Burt AD, Day CP, Anstee QM.

J Hepatol. 2014 May;60(5):1055-62. doi: 10.1016/j.jhep.2014.01.010. Epub 2014 Jan 18.

PMID:
24445215
27.

Improving access to treatment for patients with chronic hepatitis C through outreach.

Elsharkawy AM, Miller C, Hearn A, Buerstedde G, Price A, McPherson S.

Frontline Gastroenterol. 2013 Apr;4(2):125-129. doi: 10.1136/flgastro-2012-100282. Epub 2012 Dec 14.

28.

Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?

McPherson S, Anstee QM, Henderson E, Day CP, Burt AD.

Eur J Gastroenterol Hepatol. 2013 Jun;25(6):652-8. doi: 10.1097/MEG.0b013e32835d72cf.

PMID:
23325287
29.

Cholestasis secondary to anabolic steroid use in young men.

Elsharkawy AM, McPherson S, Masson S, Burt AD, Dawson RT, Hudson M.

BMJ. 2012 Feb 2;344:e468. doi: 10.1136/bmj.e468. No abstract available.

PMID:
22302781
30.

How big a problem is non-alcoholic fatty liver disease?

Anstee QM, McPherson S, Day CP.

BMJ. 2011 Jul 18;343:d3897. doi: 10.1136/bmj.d3897. No abstract available.

PMID:
21768191
31.

No evidence of the unfolded protein response in patients with chronic hepatitis C virus infection.

McPherson S, Powell EE, Barrie HD, Clouston AD, McGuckin M, Jonsson JR.

J Gastroenterol Hepatol. 2011 Feb;26(2):319-27. doi: 10.1111/j.1440-1746.2010.06368.x.

PMID:
21261722
32.

Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.

McPherson S, Stewart SF, Henderson E, Burt AD, Day CP.

Gut. 2010 Sep;59(9):1265-9. doi: 10.1136/gut.2010.216077.

PMID:
20801772
33.

Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered.

McPherson S, Jonsson JR, Cowin GJ, O'Rourke P, Clouston AD, Volp A, Horsfall L, Jothimani D, Fawcett J, Galloway GJ, Benson M, Powell EE.

J Hepatol. 2009 Aug;51(2):389-97. doi: 10.1016/j.jhep.2009.04.012. Epub 2009 May 18.

PMID:
19505740
34.

Investigation of the role of SREBP-1c in the pathogenesis of HCV-related steatosis.

McPherson S, Jonsson JR, Barrie HD, O'Rourke P, Clouston AD, Powell EE.

J Hepatol. 2008 Dec;49(6):1046-54. doi: 10.1016/j.jhep.2008.06.022. Epub 2008 Jul 15.

PMID:
18752865
35.

Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea.

McPherson S, Rees CJ, Ellis R, Soo S, Panter SJ.

Dis Colon Rectum. 2006 May;49(5):640-5.

PMID:
16525744
36.

An alcoholic patient who continues to drink: case outcome.

McPherson S, Rees CJ.

BMJ. 2006 Feb 4;332(7536):276. Review. No abstract available. Erratum in: BMJ. 2006 Feb 18;332(7538):396.

37.

Postoperative methicillin-resistant Staphylococcus aureus enteritis following hysterectomy: a case report and review of the literature.

McPherson S, Ellis R, Fawzi H, Panter SJ.

Eur J Gastroenterol Hepatol. 2005 Nov;17(11):1225-7. Review.

PMID:
16215435

Supplemental Content

Loading ...
Support Center